(Q45859098)

17 December 2017

title

The Norwegian Plasma Fractionation Project--a 12 year clinical and economic success story (English)

1 reference

17 December 2017

author name string

Flesland O

series ordinal

1

1 reference

17 December 2017

Seghatchian J

series ordinal

2

1 reference

17 December 2017

Solheim BG

series ordinal

3

1 reference

17 December 2017

publication date

1 February 2003

1 reference

17 December 2017

Transfusion and Apheresis Science

published in

1 reference

17 December 2017

volume

28

1 reference

17 December 2017

issue

1

1 reference

17 December 2017

page(s)

93-100

1 reference

17 December 2017

Liver disease in anti-hepatitis C virus-positive Norwegian blood donors

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1473-0502%2802%2900104-0

7 January 2021

Administration of intravenous immunoglobulin (IVIG) in vivo--down-regulatory effects on the IL-1 system

1 reference

https://api.crossref.org/works/10.1016%2FS1473-0502%2802%2900104-0

7 January 2021

Immunomodulating therapy with intravenous immunoglobulin in patients with chronic heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS1473-0502%2802%2900104-0

7 January 2021

Complement activation in patients with congestive heart failure: effect of high-dose intravenous immunoglobulin treatment

1 reference

https://api.crossref.org/works/10.1016%2FS1473-0502%2802%2900104-0

7 January 2021

Viral safety of solvent/detergent-treated plasma

1 reference

https://api.crossref.org/works/10.1016%2FS1473-0502%2802%2900104-0

7 January 2021

Universal solvent/detergent-treated fresh frozen plasma (Uniplas--rationale and clinical properties

1 reference

https://api.crossref.org/works/10.1016%2FS1473-0502%2802%2900104-0

7 January 2021

Viral safety of blood derivatives by immune neutralization

1 reference

https://api.crossref.org/works/10.1016%2FS1473-0502%2802%2900104-0

7 January 2021

Effects of solvent/detergent-treated plasma and fresh-frozen plasma on haemostasis and fibrinolysis in complex coagulopathy following open-heart surgery

1 reference

https://api.crossref.org/works/10.1016%2FS1473-0502%2802%2900104-0

7 January 2021

Manufacture and in vitro characterization of a solvent/detergent-treated human plasma

1 reference

https://api.crossref.org/works/10.1016%2FS1473-0502%2802%2900104-0

7 January 2021

In vitro characterization of solvent/detergent-treated human plasma and of quarantine fresh frozen plasma

1 reference

https://api.crossref.org/works/10.1016%2FS1473-0502%2802%2900104-0

7 January 2021

Coagulation factor levels in solvent/detergent-treated plasma

1 reference

https://api.crossref.org/works/10.1016%2FS1473-0502%2802%2900104-0

7 January 2021

α2-Plasmin inhibitor is among acute phase reactants

1 reference

https://api.crossref.org/works/10.1016%2FS1473-0502%2802%2900104-0

7 January 2021

Distribution of hepatitis A antibody over a process for the preparation of a high-purity factor VIII concentrate

1 reference

https://api.crossref.org/works/10.1016%2FS1473-0502%2802%2900104-0

7 January 2021

Hepatitis A virus antibody levels in factor VIII concentrates

1 reference

https://api.crossref.org/works/10.1016%2FS1473-0502%2802%2900104-0

7 January 2021

Human albumin administration in critically ill patients: systematic review of randomised controlled trials

1 reference

https://api.crossref.org/works/10.1016%2FS1473-0502%2802%2900104-0

7 January 2021

10.1016/S1473-0502(02)00104-0

Identifiers

DOI

1 reference

17 December 2017

1 reference

17 December 2017